The Effects of Increasing Fruit and Vegetable Intake in Children with Asthma on the Modulation of Innate Immune

Banafsheh Hosseini1, Bronwyn S Berthon1, Megan E Jensen2

  • 1Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW 2305, Australia.

Nutrients
|August 12, 2022
PubMed

Insights

A high fruit and vegetable diet reduced asthma exacerbations in children. This dietary intervention enhanced innate immune responses, suggesting it

Area of Science:

  • Pediatric Allergy and Immunology
  • Nutritional Immunology
  • Respiratory Medicine

Background:

  • Asthma exacerbations in children are frequently triggered by viral infections.
  • Dietary intake of fruits and vegetables (F&V), rich in carotenoids, may bolster innate immunity.
  • Children with asthma often have low F&V consumption, potentially impacting immune function.

Purpose of the Study:

  • To investigate the effect of a high F&V diet on asthma exacerbations in children.
  • To assess the impact of increased F&V intake on in-vitro immune responses in children with asthma.

Main Methods:

  • A 6-month randomized controlled trial involving children aged 3-11 years with asthma and low F&V intake.
  • Participants were assigned to either a high F&V diet or a control (usual diet) group.
  • Outcomes measured included respiratory-related adverse events and cytokine production by peripheral blood mononuclear cells (PBMCs) stimulated with rhinovirus-1B (RV1B), house dust mite (HDM), and lipopolysaccharide (LPS).

Main Results:

  • Fewer children in the high F&V diet group experienced two or more asthma exacerbations compared to the control group (63.6% vs. 88.0%, p = 0.049).
  • Lipopolysaccharide (LPS)-induced interferon (IFN)-γ and IFN-λ production increased significantly in the high F&V group after 3 months.
  • RV1B-induced IFN-λ production in PBMCs positively correlated with changes in plasma lycopene levels at 6 months.

Conclusions:

  • A high F&V diet effectively reduced asthma-related illness in young children.
  • Increased F&V intake modulated in-vitro cytokine production, enhancing innate immune responses.
  • Dietary improvement through higher F&V consumption is a promising non-pharmacological strategy for asthma management.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
549
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
415
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
429
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.6K